文献速递消化与肝胆胰病理细胞病理与分子病理

FNA活检在胰腺神经内分泌肿瘤分级中的诊断价值

The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors.
PubMed 文献 · Cancer Cytopathol · 2017-12-19

研究评估27例胰腺神经内分泌肿瘤(PNET)FNA标本与对应手术切除标本的Ki-67增殖指数分级一致性。26例FNA中22例(84.6%)分级与手术标本可比,区分1级与2级肿瘤的阳性预测值为88.9%,灵敏度72.7%,特异度93.3%,P值.00081。多数样本细胞数少于2000甚至1000仍可正确分级。

要点

  • FNA标本Ki-67指数分级与手术切除标本分级一致性良好。
  • 区分1级与2级肿瘤的阳性预测值88.9%,灵敏度72.7%,特异度93.3%。
  • 即使细胞数少于推荐总量(含仅50个细胞)也可获得正确分级。

核心结论

  • FNA标本Ki-67指数分级与手术切除标本最终分级相关性良好。
  • 即使样本细胞数低于推荐总量,FNA分级仍可评估且应报告给临床医生。

研究设计与样本

  • 病例系列研究,纳入27例有FNA活检及对应手术切除标本的PNET。
  • 按2010年WHO标准评估FNA与手术标本的Ki-67指数分级。
  • 查阅病历评估保守观察患者的复发或临床进展。

主要发现

  • 26例FNA中22例(84.6%)Ki-67结果与对应手术切除标本可比,可准确分级。
  • FNA正确诊断并区分1级与2级肿瘤的阳性预测值88.9%,灵敏度72.7%,特异度93.3%,P值.00081。
  • 26例中24例细胞数少于2000,其中20例FNA正确分级。
  • 26例FNA中7例细胞数少于1000,其中6例正确分级,包括2例仅50个细胞。

关键数值与推荐

  • 采用2010年WHO标准依据Ki-67增殖指数进行分级。
  • FNA与手术标本分级一致者26例中22例(84.6%)。
  • 区分1级与2级肿瘤的阳性预测值88.9%,灵敏度72.7%,特异度93.3%,P值.00081。
  • 细胞数少于2000者24例中20例正确分级;少于1000者7例中6例正确分级。

临床怎么用

  • 对PNET的FNA标本应评估Ki-67增殖指数并报告分级。
  • 即使细胞数较少(包括仅50个细胞)也可尝试分级,不应轻易放弃。

局限性

  • 病例系列样本量较小(27例PNET)。
  • 单中心回顾性设计,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There has been much controversy regarding the accuracy of grading pancreatic neuroendocrine tumors (PNETs) on fine-needle aspiration (FNA) biopsy. The objectives of this study were to evaluate whether grading according to the fraction of Ki-67-positive tumor cells (the Ki-67 proliferation index) on material from endoscopic ultrasound-guided FNA biopsies correlated with grading on surgical resection specimens and to evaluate the minimum amount of FNA material needed. METHODS: A case series of 27 PNETs with FNA biopsies and corresponding surgical resection specimens at the authors' institution were evaluated. Tumors were graded on FNA and surgical specimens with an evaluation of Ki-67 index according to 2010 World Health Organization criteria. Chart reviews were conducted to evaluate recurrence or clinical progression in patients who were being managed conservatively with observation. RESULTS: The evaluation of grading between FNA and tumor resection specimens revealed that 22 of 26 FNA specimens (84.6%) had Ki-67 results comparable to those in the corresponding surgical resection specimens, thus allowing for accurate grading. Correct FNA diagnosis with the ability to distinguish between grade 1 and 2 tumors had a positive predictive value of 88.9%, with 72.7% sensitivity, 93.3% specificity, and a P value of .00081. In addition, 24 of 26 cases contained less than 2000 cells, of which 20 were correctly graded on FNA material. Seven of 26 FNA samples had less than 1000 cells, of which 6 were correctly graded, including 2 that had only 50 cells. CONCLUSIONS: The current results exhibit good correlation between FNA grade and final grade on surgical resection specimens using Ki-67 index, even in samples with less than the recommended total cell count. Therefore, grading of PNETs on FNA with the Ki-67 proliferation index should be assessed and is a practical parameter to report to clinicians. Cancer Cytopathol 2018;126:170-8. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Laskiewicz L, Jamshed S, Gong Y, et al. The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors. Cancer Cytopathol. 2017. PMID: 29266776. doi:10.1002/cncy.21956

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。